1. Younossi, ZM, Koenig, AB, Abdelatif, D, et al Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73–84.
Google Scholar | Crossref | Medline | ISI2. Adams, LA, Anstee, QM, Tilg, H, et al Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017; 66: 1138–1153.
Google Scholar | Crossref | Medline3. Ekstedt, M, Hagström, H, Nasr, P, et al Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015; 61: 1547–1554.
Google Scholar | Crossref | Medline4. Stefan, N, Häring, H-U, Cusi, K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol 2019; 7: 313–324.
Google Scholar | Crossref | Medline5. Kim, SU, Song, D, Heo, JH, et al Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke. Atherosclerosis 2017; 260: 156–162.
Google Scholar | Crossref | Medline6. Hagström, H, Nasr, P, Ekstedt, M, et al Cardiovascular risk factors in non-alcoholic fatty liver disease. Liver Int 2019; 39: 197–204.
Google Scholar | Crossref | Medline7. Parikh, NS, VanWagner, LB, Elkind, MSV, et al Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke. J Neurol Sci 2019; 407: 116524.
Google Scholar | Crossref | Medline8. Baik, M, Kim, SU, Kang, S, et al Liver fibrosis, not steatosis, associates with long-term outcomes in ischaemic stroke patients. Cerebrovasc Dis 2019; 47: 32–39.
Google Scholar | Crossref | Medline9. Parikh, NS, Kamel, H, Navi, BB, et al Liver fibrosis indices and outcomes after primary intracerebral hemorrhage. Stroke 2020; 51: 830–837.
Google Scholar | Crossref | Medline10. Kaesmacher, J, Kaesmacher, M, Maegerlein, C, et al Hemorrhagic transformations after thrombectomy: risk factors and clinical relevance. Cerebrovasc Dis 2017; 43: 294–304.
Google Scholar | Crossref | Medline11. Fandler-Höfler, S, Heschl, S, Kneihsl, M, et al Ventilation time and prognosis after stroke thrombectomy: the shorter, the better! Eur J Neurol 2020; 27: 849–855.
Google Scholar | Crossref | Medline12. Sterling, RK, Lissen, E, Clumeck, N, et al Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317–1325.
Google Scholar | Crossref | Medline | ISI13. Chalasani, N, Younossi, Z, Lavine, JE, et al The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67: 328–357.
Google Scholar | Crossref | Medline14. Shah, AG, Lydecker, A, Murray, K, et al Use of the FIB4 index for non-invasive evaluation of fibrosis in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 1104–1112.
Google Scholar | Crossref | Medline15. Staufer, K, Halilbasic, E, Spindelboeck, W, et al Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United European Gastroenterol J 2019; 7: 1113–1123.
Google Scholar | SAGE Journals | ISI16. Forns, X, Ampurdanès, S, Llovet, JM, et al Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986–992.
Google Scholar | Crossref | Medline | ISI17. Boursier, J, de Ledinghen, V, Leroy, V, et al A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis. J Hepatol 2017; 66: 1158–1165.
Google Scholar | Crossref | Medline18. Hacke, W, Kaste, M, Fieschi, C, et al Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017–1025.
Google Scholar | Crossref | Medline | ISI19. Gattringer, T, Enzinger, C, Fischer, R, et al IV thrombolysis in patients with ischemic stroke and alcohol abuse. Neurology 2015; 85: 1592–1597.
Google Scholar | Crossref | Medline20. Baik, M, Nam, HS, Heo, JH, et al Advanced liver fibrosis predicts unfavorable long-term prognosis in first-ever ischemic stroke or transient ischemic attack. Cerebrovasc Dis 2020; 49: 474–480.
Google Scholar | Crossref | Medline21. Wijarnpreecha, K, Boonpheng, B, Thongprayoon, C, et al The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis. Clin Res Hepatol Gastroenterol 2017; 41: 525–532.
Google Scholar | Crossref | Medline22. du Plessis, J, van Pelt, J, Korf, H, et al Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology 2015; 149: 635–648.e14.
Google Scholar | Crossref | Medline | ISI23. Verrijken, A, Francque, S, Mertens, I, et al Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 2014; 59: 121–129.
Google Scholar | Crossref | Medline24. Villanova, N, Moscatiello, S, Ramilli, S, et al Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473–480.
Google Scholar | Crossref | Medline25. Francque, SM, van der Graaff, D, Kwanten, WJ. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol 2016; 65: 425–443.
Google Scholar | Crossref | Medline26. Madan, SA, John, F, Pyrsopoulos, N, et al Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis. Eur J Gastroenterol Hepatol 2015; 27: 1237–1248.
Google Scholar | Crossref | Medline27. VanWagner, LB, Wilcox, JE, Colangelo, LA, et al Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 2015; 62: 773–783.
Google Scholar | Crossref | Medline28. Ruban, A, Daya, N, Schneider, ALC, et al Liver enzymes and risk of stroke: the Atherosclerosis Risk in Communities (ARIC) study. J Stroke 2020; 22: 357–368.
Google Scholar | Crossref | Medline